Downregulation of miR-483-5p decreases hypoxia-induced injury in human cardiomyocytes by targeting MAPK3.

Conclusions: MiR-483-5p, which targets MAPK3, might be a potential therapeutic target for the diagnosis and prevention of hypoxia-induced myocardial injury. PMID: 32206064 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32206064?dopt=Abstract

Source: Cellular and Molecular Biology Letters - March 26, 2020 Category: Biochemistry Authors: Hao Y, Yuan H, Yu H Tags: Cell Mol Biol Lett Source Type: research